Drug slows kidney decline in non-diabetics

An international study has discovered that the drug "Venirion" significantly slows the deterioration of kidney function in patients without diabetes, after monitoring more than 1,500 patients over a period of more than three years. The results showed that the use of the drug reduced the risks of kidney function decline and lowered protein levels in the urine by more than 41 percent, enhancing treatment prospects for chronic kidney disease not related to diabetes.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل